We are committed to serving the current needs of IM's customers while investing in the analytical data solutions they'll need moving forward. Adding the newly-named Source product portfolio to our intelligence products in drug discovery and development provides the foundation for a powerful suite of value-added content tools that will help our customers be more successful in their markets. |